Current Research Studies

A Phase 1 Study of FOLR1 CAR T for Pediatric Patients with FOLR1/CBFA2T3::GLIS2+ Relapsed or Refractory AML

FOLR1 CAR T

  • Condition(s): Myeloid and Monocytic Leukemia
  • Phase: I
  • Clinicaltrials.gov ID: NCT06609928

What is the goal of the study?

This phase 1, open-label, non-randomized study will enroll pediatric patients with relapsed or refractory FOLR1+ acute myeloid leukemia with and without prior history of allogeneic hematopoietic cell transplantation, to examine the safety and feasibility of administering an autologous T cell product that has been genetically modified to express FOLR1 CAR.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: